Indian Journal of Public Health Research & Development

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Clinical Use and Safety of Medical Method of first Trimester Abortion


Affiliations
1 Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
2 Department of Anatomy, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
4 Department of Surgical Oncology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
     

   Subscribe/Renew Journal


Introduction

Women have a right to undergo an abortion if she wishes. Medical abortion is legally accepted under the Indian law. Mifepristone and misoprostol combination offers a safe, nonsurgical alternative for pregnancy termination with good success rates.

Aims and Objectives

The purpose of this study was to evaluation of the clinical efficacy of the combination of mifepristone and misoprostol orally for early termination of pregnancy.

Methods

A prospective clinical study conducted during a one year period included 100 healthy pregnant women consenting for a legal abortion with an ammenorrhoea of no more than 63 days.

Results

This method had a success rate of 94%, with an average induction abortion interval between 40-50 hours, one women needed surgical curettage. No serious side effects expect for nausea was noted.

Conclusion

The combination of mifepristone and misoprostol is effective for the termination of early pregnancy in terms of success, tolerance, safety and practicality.


Subscription Login to verify subscription
User
Notifications
Font Size


  • Manju MV. Jassawalla MJ. Manual ontermination of pregnancy, 3rd edn., 1999;9-11,55-59.

  • WHO : Pregnancy termination with mifepristone and semeprost – A multicentre comparison between repeated doses and a single dose of mifepristone; fertile steril; 1991:56:32-40.

  • Norman JE, Kelly RW, Glasler AF. Effects of Mifepristone in vivo on decidual prostaglandin synthesis and metabolism; contraception; 1991;49:88-89.

  • Usha K. Antiprogesterons, today and tomarrow, review article. J Obs Gynec 2000;26-34.

  • Wel SG et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and PGO5 – a multicentre randomized clinical trial in china; Contraception; 1994;50:501- 510.

  • Birgerson L, Odlind V. Early pregnancy termination with antiprogestins : a comparative clinical study of Ru 486 given in two dose regimens and epostane, Fertil Steril 1987;48(4):565- 70.

  • Remi P, Elisabeth A et al. Early termination of pregnancy with mifepristone and the orally active prostaglandin misoprostol, N Engl J Med 1993;328:1509-13.

  • Bahzad C, Wyssling H, Saraya, Yougen S. Termination of early human pregnancy with mifepristone and the prostaglandin analogue sulprostone; a multicentre randomized comparison between two treatment regimens; Oxford J Human Reprod 1989;4(6):718-725.

  • Beatrice C, LeNelly S, Andre U et al. Termination of early pregnancy by the progesterone antagonist Ru (486) Mifepristone, N Engl J Med, 1996;315:1565-1570.

  • UK Multicentre trial : The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy, Br J Obstet Gynaecol; 1998;97:480-86.

  • Florence D, Catherine D, Joelle B, Rene F. Efficacy of progesterone antagonist Ru 486 (Mifepristone) for preoperative cervical dilatation during first trimester abortion, Oxford J Human Reproduct 1988;3(5):583-84.


Abstract Views: 209

PDF Views: 0




  • Clinical Use and Safety of Medical Method of first Trimester Abortion

Abstract Views: 209  |  PDF Views: 0

Authors

Geetha Hosanemati
Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
Gayatri Patil
Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
Prema Prabhudev
Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
M. R. Anitha
Department of Anatomy, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
V. Vijayanath
Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India
L. S. Patil
Department of Surgical Oncology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, India

Abstract


Introduction

Women have a right to undergo an abortion if she wishes. Medical abortion is legally accepted under the Indian law. Mifepristone and misoprostol combination offers a safe, nonsurgical alternative for pregnancy termination with good success rates.

Aims and Objectives

The purpose of this study was to evaluation of the clinical efficacy of the combination of mifepristone and misoprostol orally for early termination of pregnancy.

Methods

A prospective clinical study conducted during a one year period included 100 healthy pregnant women consenting for a legal abortion with an ammenorrhoea of no more than 63 days.

Results

This method had a success rate of 94%, with an average induction abortion interval between 40-50 hours, one women needed surgical curettage. No serious side effects expect for nausea was noted.

Conclusion

The combination of mifepristone and misoprostol is effective for the termination of early pregnancy in terms of success, tolerance, safety and practicality.


References